Douglas Laboratories

Pack #2, Wobenzym N

F
N+ Score51
Vitamins & MineralsServing: 3 Tablet(s)Type: Non-Nutrient/Non-Botanical

Pack #2, Wobenzym N from Douglas Laboratories is a non-nutrient/non-botanical supplement containing a blend of enzymes and rutoside trihydrate. Each serving of three tablets provides Pancreatin (300mg), Papain (180mg), Bromelain (135mg), Trypsin (72mg), Chymotrypsin (3mg), and Rutoside Trihydrate (150mg). This product received an N+ Score of 51, earning an 'F' grade, indicating a below-average rating in our analysis. While the label transparency is 100%, the formula's ingredient adequacy and completeness scores are low, suggesting that the dosages of the included ingredients may not align with established clinical research for their intended effects. This product might be considered by individuals interested in enzyme blends, but its low N+ Score suggests potential limitations in efficacy based on current scientific understanding.

About This Product

Pack #2, Wobenzym N by Douglas Laboratories is a vitamins & minerals supplement containing 6 active ingredients. It has earned an N+ Score of 51/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity65/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (6 ingredients)

IngredientAmountDose Adequacy
Pancreatin300.000 mgN/A
Bromelain135.000 mgN/A
Papain180.000 mgN/A
Trypsin72.000 mgN/A
Chymotrypsin3.000 mgN/A
Rutoside Trihydrate150.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.